A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.

Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the synthesis of dystrophin protein. Antisense oligonucleotides (AOs) targeted to trigger excision of an exon bearing a mutant premature stop codon in the DMD transcript have been shown to skip the mutated exon and...

詳細記述

書誌詳細
主要な著者: Yin, H, Moulton, H, Betts, C, Seow, Y, Boutilier, J, Iverson, P, Wood, M
フォーマット: Journal article
言語:English
出版事項: 2009

類似資料